pharmaphorum
NOVEMBER 17, 2020
This pharmaphorum webinar, held in association with the National Institute for Health Research (NIHR), takes place on Wednesday 16 th December, 11:00 GMT / 12:00 CET and will look at how to navigate the compliance pathway to increase patient engagement with clinical trials. Gaining patient input on marketing and recruitment materials.
pharmaphorum
JANUARY 26, 2023
The document from the Prescription Medicines Code of Practice Authority (PMCPA) arrives in the wake of several cases where drugmakers made promotional statements on social media platforms – including LinkedIn and Instagram – that were deemed to have breached the code of practice laid down by the Association of British Pharmaceutical Industry (APBI).
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Channels
NOVEMBER 15, 2023
In Medicare Part D in 2024: The Seven Largest Companies' Preferred Pharmacy Networks and the Coming Collapse of the PDP Market , I documented how those networks now dominate stand-alone Medicare Part D prescription drug plans (PDPs) and have become a major presence in Medicare Advantage prescription drug (MA-PD) plans. to 1:30 p.m.
Drug Channels
DECEMBER 14, 2021
This week, I’m rerunning some popular posts while I prepare for this Friday’s live video webinar: Drug Channels Outlook 2022. I document this disappointing state of affairs below. Click here to see the original post and comments from July 2021. I’m sad to report that this year’s analysis is skimpier than usual.
pharmaphorum
NOVEMBER 15, 2021
That was among the key messages from speakers at a joint European Forum for Good Clinical Practice (EFGCP) and the European Federation of Pharmaceutical Industries and Associations (EFPIA) webinar, held last week. This should cover the entire process, “starting with the writing, the review of the document, and its dissemination”.
Drug Channels
AUGUST 6, 2024
I then document how five multi-billion-dollar, for-profit, publicly traded pharmacy chains and pharmacy benefit managers (PBMs)—Cigna (via Express Scripts), CVS Health, UnitedHealth Group (via OptumRx), and Walgreens, Walmart—continue to dominate the 340B contract pharmacy market.
pharmaphorum
FEBRUARY 11, 2021
In a recent webinar from pharmaphorum, the National Institute for Health Research (NIHR) outlined why and how it has developed a new approach to engage with patients while complying with national regulations, such as those set out in the Association of the British Pharmaceutical Industry’s (ABPI) Code of Practice.
Expert insights. Personalized for you.
116 
Let's personalize your content